What is causing the recently noted mild decline in national obesity rates?

icon-person

Our Team

icon-calendar

3/18/2025

Recently published data suggested that, for the first time in many years, national obesity rates have mildly declined in 2023 after plateauing in 2022 (1) (the figure below stems from a recent report by the National Center for Health Statistics). 

Recently published data sugges

The most notable decrease was in the South, which – interestingly – also had the highest observed per capita GLP-1 receptor agonist (GLP-1RA) dispensing rate. The paper reporting this decline, however, also noted that dispensing does not necessarily mean uptake. The South, indeed, also experienced disproportionately high COVID-19 mortality among individuals with obesity.

A recent Commentary in Medscape Diabetes & Endocrinology, argued that the increasingly popular GLP-1RAs do not explain this observed drop in obesity and that other factors must have played a role (2).

For us somewhat far-fetched, however, appears the argument in the paper that excessive mortality of obese patients during the COVID pandemic may have affected obesity rates. Moreover, more severe COVID cases among obese patients, according to this author, may have led to significant weight loss. He unquestionably was, however, correct that first and second generation GLP-1Ras were FDA-approved only after the national obesity rate had already plateaued. 

The author of the article correct in acknowledging that with increasing utilization of especially second-generation medications like tirzepatide (in the U.S. sold as Munjaro) the national obesity crisis must be expected to improve further, as a just recently published study demonstrated a whopping 25.3% weight loss in obese patients at 88 weeks of treatment with these drugs. And it, of course, is not only about weight loss as an end goal; weight loss also improves fertility and, ultimately, general health and life expectancy.

References

1.      Rader et al., JAMA Health Forum 2024; 5(12):e243685

2.      Freedhoff Y. Medscape  Diabetes and Endocrinology. January 17, 2025. https://www.medscape.com/viewarticle/obesity-medications-dont-explain-decrease-obesity-rates-2025a10000in 

Our daughter had her first birthday on February 6th. She’s extremely smart, and super sweet. She brings us so much joy, and we can never adequately thank Dr. Barad enough for all his help to make it possible!

B.B. Office Visit

The best Dr thanks to him our family dream came true🙏 Thank you so much dr I recommend him 100%

F.G. Google

CHR has a wonderful team, and Dr. Barad is the best.

R.K. Google

Great experience overall! From the moment we entered the door we were greeted with beautiful smiles, greatest personality front desk employees and kindest and most knowledgeable medical professionals. I would list names but everyone employed by CHR deserves the most heartfelt recognition!Dr. Barad and Dr. GleiCher are performing IVF medical miracles if you ask me. We were kept informed about the next steps in our medical journey and the procedures were all don't on site with no stress at all.

M.P. Yelp

There are no words that could truly explain how the entire CHR team has impacted our lives. We conceived our daughter there almost three years ago and are now trying for our second child. There is no where else I would ever consider going. Every time I walk into the office I feel like I am with my family. We chat, we laugh, we cry… It is truly a very special group of people. Dr. Barad is patient, kind & compassionate. My nurse Maria’s level of detail and care is beyond anything I could have imagined. I could easily name at least a dozen more team members that are absolutely incredible. I would recommend CHR to anyone on their fertility journey.

J.B. Google

215

Total Reviews

4.9

Average Rating

star-full star-full star-full star-full star-half
privacy We respect your privacy
*All information subject to change. Images may contain models. Individual results are not guaranteed and may vary.